✦ LIBER ✦

Additional prognostic value of the 70-gene signature (MammaPrint®) among breast cancer patients with 4–9 positive lymph nodes

✍ Scribed by Saghatchian, M.; Mook, S.; Pruneri, G.; Viale, G.; Glas, A.M.; Guerin, S.; Cardoso, F.; Piccart, M.; Tursz, T.; Delaloge, S.; van't Veer, L.

Book ID: 122655031
Publisher: Elsevier Science
Year: 2013
Tongue: English
Weight: 543 KB
Volume: 22
Category: Article
ISSN: 0960-9776
DOI: 10.1016/j.breast.2012.12.002

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

0071 The 70-gene MammaPrint profile allo

0071 The 70-gene MammaPrint profile allows to identify a subgroup of very good-prognostic patients with primary breast cancer and 4-9 positive lymph nodes

✍ M. Saghatchian; S. Mook; G. Pruneri; G. Viale; A. Glas; I. Eekhout; M. Knauer; L 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

The 70-gene prognosis-signature predicts

The 70-gene prognosis-signature predicts disease outcome in breast cancer patients with 1–3 positive lymph nodes in an independent validation study

✍ Stella Mook; Marjanka K. Schmidt; Giuseppe Viale; Giancarlo Pruneri; Inge Eekhou 📂 Article 📅 2008 🏛 Springer US 🌐 English ⚖ 303 KB

43LBA Combining genomic profiling (70-ge

43LBA Combining genomic profiling (70-gene MammaPrint) with nodal status allows to classifypatients with primary breast cancer and positive lymph nodes (1-9) into very distinct prognostic subgroups that could help tailor treatment strategies.

✍ M. Saghatchian; S. Mook; G. Pruneri; G. Viale; A. Glas; I. Eekhout; S. Delaloge; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 47 KB

Economic evaluation of the 70-gene progn

Economic evaluation of the 70-gene prognosis-signature (MammaPrint®) in hormone receptor-positive, lymph node-negative, human epidermal growth factor receptor type 2-negative early stage breast cancer in Japan

✍ Masahide Kondo, Shu-Ling Hoshi, Hiroshi Ishiguro, Masakazu Toi 📂 Article 📅 2012 🏛 Springer US 🌐 English ⚖ 281 KB

The 70-gene profile is a powerful predic

The 70-gene profile is a powerful predictor of disease outcome in breast cancer patients with 1–3 positive lymph nodes

✍ S. Mook; M.K. Schmidt; G. Viale; G. Pruneri; I. Eekhout; M.J. Piccart-Gebhart; F 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 60 KB